Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer

Johnny Kao, Eric M. Genden, Chien Ting Chen, Michael Rivera, Charles C.L. Tong, Kryztof Misiukiewicz, Vishal Gupta, Vivek Gurudutt, Marita Teng, Stuart H. Packer

Research output: Contribution to journalArticlepeer-review

48 Scopus citations

Fingerprint Dive into the research topics of 'Phase 1 trial of concurrent erlotinib, celecoxib, and reirradiation for recurrent head and neck cancer'. Together they form a unique fingerprint.

Medicine & Life Sciences